Ocean Biomedical, Inc.


Ocean Biomedical, Inc. Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg, SEC Filings

Report Link: Updated Research Report (Dated September 19, 2023)

Symbol: OCEA
Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: $18.50
Time Horizon: 12 Months
Rating Established: May 30, 2023
Price When Established: $5.17
Most Recent Report: September 19, 2023
Price When Issued: $4.12

What’s New

New information will be posted soon…

Company Description

Ocean Biomedical, Inc. (OCEA) headquartered in Providence, Rhode Island is biopharmaceutical organization that is deploying a business model that bridges the bench-to-bedside gap by accelerating the commercialization of innovative assets contained within research universities and medical centers. The company’s initial preclinical programs include candidates for lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria

Please view our current disclosure and disclaimer on our most recent research report.